Skip to main content
    I

    Instil Bio Inc. (TIL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.75
    -0.33 (-5.43%)

    Market Cap: $41.23M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Instil Bio Inc. (TIL) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Instil Bio (TIL) to earn -$1.17 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the quarter ending Dec 31, 2026, the EPS consensus is -$0.04.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    Fiscal year ending Dec 31, 2026
    -$1.17
    EPS consensus
    Next report
    Mar 25, 2027
    Estimated
    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$1.17-$1.17 to -$1.171

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.04-$0.04 to -$0.042

    Estimate Revisions

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$1.61.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$1.17-$1.17-$1.17-$1.61-$1.61N/A

    Frequently Asked Questions About TIL

    What is the TIL stock forecast?

    Consensus analyst estimates put Instil Bio's EPS at -$1.17 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from TIL next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.17, with estimates from -$1.17 to -$1.17 from 1 analyst.

    How many analysts cover TIL?

    1 analyst estimates EPS for Instil Bio for the fiscal year ending Dec 31, 2026.